Review




Structured Review

Five Prime cdna encoding human brd4
Cdna Encoding Human Brd4, supplied by Five Prime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+cdna/cdna+encoding+human+brd4/pm29776834-460-0-12
Average 90 stars, based on 1 article reviews
cdna encoding human brd4 - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

other:

Article Title: Inhibitors of transcription factors and uses thereof
Article Snippet: Media, trypsin, and antibiotics for tissue culture were purchased from MediatechCloning. cDNA encoding human BRD2, BRD3, BRD4, BRDT, CREBBP and WDR9 (NCBI accession number NP 005095, NP 031397.1, NP 055114.1, NP 001717.2, NP 004371.1, NP 061836.2) were obtained from different sources (BRD2: Synthetic, BRD3: Origene, BRD4: FivePrime, BRDT: IMAGE collection, CREBBP: Synthetic, WDR9: synthetic) and used as templates to amplify the bromodomain regions of the above proteins, using the polymerase chain reaction (PCR) in the presence of Platinum® Pfx DNA polymerase (InvitrogenTM, UK).



Similar Products

90
Addgene inc cdna of full-length brd4
Cdna Of Full Length Brd4, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+cdna/gfp+brd2/bio_rxiv__2024__09__24__614843-263-1-11
Average 90 stars, based on 1 article reviews
cdna of full-length brd4 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

91
Addgene inc brd4 det cdna
Brd4 Det Cdna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+cdna/pFlag-CMV2-Brd4+del+ET+(Plasmid+%2321938)/pm37442129-179-15-21
Average 91 stars, based on 1 article reviews
brd4 det cdna - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

93
Addgene inc brd4 fl cdna
Brd4 Fl Cdna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+cdna/p6344+pcDNA4-TO-HA-Brd4FL+(Plasmid+%2331351)/pm37442129-179-11-21
Average 93 stars, based on 1 article reviews
brd4 fl cdna - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Addgene inc brd4 cdna
p113 physically interacts with ZRF1 and <t>BRD4</t> in NB cells. a Volcano plots showing differentially expressed genes (fold change> 1.5, P < 0.05) in SH-SY5Y cells stably transfected with empty vector (mock) or ecircCUX1 . b Coomassie blue staining (left panel) and Venn diagram (right panel) revealing identification of p113-interacting proteins pulled down by p113 or Flag-tag antibody in SH-SY5Y cells stably transfected with 3Flag-tagged p113 , and those overlapped with transcription factors (TF) or epigenetic factors derived from ChIP-X and EpiFactors databases. c Co-IP and western blot assays indicating the interaction among p113, ZRF1, and BRD4 in SH-SY5Y and BE(2)-C cells stably transfected with mock, ecircCUX1 , scramble shRNA (sh-Scb), or sh-ecircCUX1. d Secondary co-IP assays showing protein interaction among p113, ZRF1, and BRD4 in SH-SY5Y cells stably transfected with HA-tagged p113 , Flag-tagged ZRF1 , and His-tagged BRD4 . e BiFC assay revealing the interaction of p113 with ZRF1 or BRD4 (arrowheads) in SH-SY5Y cells stably transfected with indicated constructs, with nuclei stained by DAPI. Scale bars: 10 μm. f and g Western blot assay (g) validating the knockdown of ZRF1 or BRD4 in SH-SY5Y cells stably transfected with scramble (Scb) or specific sgRNA for CRISPR interference (CRISPRi, f). Wild type (WT) cells were taken as negative controls. h Co-IP and western blot assays indicating the interaction of p113 with ZRF1 or BRD4 in SH-SY5Y cells stably transfected with mock or ecircCUX1 , and those co-transfected with CRISPRi sgRNA specific against ZRF1 or BRD4 . i Schematic illustration of protein interaction among p113, ZRF1, and BRD4. j Dual-luciferase assay showing the activity of ZRF1 in NB cells stably transfected with mock, ecircCUX1 , ecircCUX1 Mut, p113 , sh-Scb, or sh-ecircCUX1 ( n = 5). Fisher’s exact test for overlapping analysis in b . ANOVA compared the difference in j . * P < 0.05 vs. mock or sh-Scb. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in c - e , g , h and j
Brd4 Cdna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+cdna/BRD4+(LONG+ISOFORM)_pLX307+(Plasmid+%2398318)/pmc08474885-68-10-20
Average 93 stars, based on 1 article reviews
brd4 cdna - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
Promega cdna for human brd4 fhc11882
p113 physically interacts with ZRF1 and <t>BRD4</t> in NB cells. a Volcano plots showing differentially expressed genes (fold change> 1.5, P < 0.05) in SH-SY5Y cells stably transfected with empty vector (mock) or ecircCUX1 . b Coomassie blue staining (left panel) and Venn diagram (right panel) revealing identification of p113-interacting proteins pulled down by p113 or Flag-tag antibody in SH-SY5Y cells stably transfected with 3Flag-tagged p113 , and those overlapped with transcription factors (TF) or epigenetic factors derived from ChIP-X and EpiFactors databases. c Co-IP and western blot assays indicating the interaction among p113, ZRF1, and BRD4 in SH-SY5Y and BE(2)-C cells stably transfected with mock, ecircCUX1 , scramble shRNA (sh-Scb), or sh-ecircCUX1. d Secondary co-IP assays showing protein interaction among p113, ZRF1, and BRD4 in SH-SY5Y cells stably transfected with HA-tagged p113 , Flag-tagged ZRF1 , and His-tagged BRD4 . e BiFC assay revealing the interaction of p113 with ZRF1 or BRD4 (arrowheads) in SH-SY5Y cells stably transfected with indicated constructs, with nuclei stained by DAPI. Scale bars: 10 μm. f and g Western blot assay (g) validating the knockdown of ZRF1 or BRD4 in SH-SY5Y cells stably transfected with scramble (Scb) or specific sgRNA for CRISPR interference (CRISPRi, f). Wild type (WT) cells were taken as negative controls. h Co-IP and western blot assays indicating the interaction of p113 with ZRF1 or BRD4 in SH-SY5Y cells stably transfected with mock or ecircCUX1 , and those co-transfected with CRISPRi sgRNA specific against ZRF1 or BRD4 . i Schematic illustration of protein interaction among p113, ZRF1, and BRD4. j Dual-luciferase assay showing the activity of ZRF1 in NB cells stably transfected with mock, ecircCUX1 , ecircCUX1 Mut, p113 , sh-Scb, or sh-ecircCUX1 ( n = 5). Fisher’s exact test for overlapping analysis in b . ANOVA compared the difference in j . * P < 0.05 vs. mock or sh-Scb. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in c - e , g , h and j
Cdna For Human Brd4 Fhc11882, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+cdna/hibit+brd4/pm32997115-51-1-9
Average 90 stars, based on 1 article reviews
cdna for human brd4 fhc11882 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Five Prime cdna encoding human brd4
p113 physically interacts with ZRF1 and <t>BRD4</t> in NB cells. a Volcano plots showing differentially expressed genes (fold change> 1.5, P < 0.05) in SH-SY5Y cells stably transfected with empty vector (mock) or ecircCUX1 . b Coomassie blue staining (left panel) and Venn diagram (right panel) revealing identification of p113-interacting proteins pulled down by p113 or Flag-tag antibody in SH-SY5Y cells stably transfected with 3Flag-tagged p113 , and those overlapped with transcription factors (TF) or epigenetic factors derived from ChIP-X and EpiFactors databases. c Co-IP and western blot assays indicating the interaction among p113, ZRF1, and BRD4 in SH-SY5Y and BE(2)-C cells stably transfected with mock, ecircCUX1 , scramble shRNA (sh-Scb), or sh-ecircCUX1. d Secondary co-IP assays showing protein interaction among p113, ZRF1, and BRD4 in SH-SY5Y cells stably transfected with HA-tagged p113 , Flag-tagged ZRF1 , and His-tagged BRD4 . e BiFC assay revealing the interaction of p113 with ZRF1 or BRD4 (arrowheads) in SH-SY5Y cells stably transfected with indicated constructs, with nuclei stained by DAPI. Scale bars: 10 μm. f and g Western blot assay (g) validating the knockdown of ZRF1 or BRD4 in SH-SY5Y cells stably transfected with scramble (Scb) or specific sgRNA for CRISPR interference (CRISPRi, f). Wild type (WT) cells were taken as negative controls. h Co-IP and western blot assays indicating the interaction of p113 with ZRF1 or BRD4 in SH-SY5Y cells stably transfected with mock or ecircCUX1 , and those co-transfected with CRISPRi sgRNA specific against ZRF1 or BRD4 . i Schematic illustration of protein interaction among p113, ZRF1, and BRD4. j Dual-luciferase assay showing the activity of ZRF1 in NB cells stably transfected with mock, ecircCUX1 , ecircCUX1 Mut, p113 , sh-Scb, or sh-ecircCUX1 ( n = 5). Fisher’s exact test for overlapping analysis in b . ANOVA compared the difference in j . * P < 0.05 vs. mock or sh-Scb. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in c - e , g , h and j
Cdna Encoding Human Brd4, supplied by Five Prime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+cdna/cdna+encoding+human+brd4/pm29776834-460-0-12
Average 90 stars, based on 1 article reviews
cdna encoding human brd4 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma human brd4 cdna
p113 physically interacts with ZRF1 and <t>BRD4</t> in NB cells. a Volcano plots showing differentially expressed genes (fold change> 1.5, P < 0.05) in SH-SY5Y cells stably transfected with empty vector (mock) or ecircCUX1 . b Coomassie blue staining (left panel) and Venn diagram (right panel) revealing identification of p113-interacting proteins pulled down by p113 or Flag-tag antibody in SH-SY5Y cells stably transfected with 3Flag-tagged p113 , and those overlapped with transcription factors (TF) or epigenetic factors derived from ChIP-X and EpiFactors databases. c Co-IP and western blot assays indicating the interaction among p113, ZRF1, and BRD4 in SH-SY5Y and BE(2)-C cells stably transfected with mock, ecircCUX1 , scramble shRNA (sh-Scb), or sh-ecircCUX1. d Secondary co-IP assays showing protein interaction among p113, ZRF1, and BRD4 in SH-SY5Y cells stably transfected with HA-tagged p113 , Flag-tagged ZRF1 , and His-tagged BRD4 . e BiFC assay revealing the interaction of p113 with ZRF1 or BRD4 (arrowheads) in SH-SY5Y cells stably transfected with indicated constructs, with nuclei stained by DAPI. Scale bars: 10 μm. f and g Western blot assay (g) validating the knockdown of ZRF1 or BRD4 in SH-SY5Y cells stably transfected with scramble (Scb) or specific sgRNA for CRISPR interference (CRISPRi, f). Wild type (WT) cells were taken as negative controls. h Co-IP and western blot assays indicating the interaction of p113 with ZRF1 or BRD4 in SH-SY5Y cells stably transfected with mock or ecircCUX1 , and those co-transfected with CRISPRi sgRNA specific against ZRF1 or BRD4 . i Schematic illustration of protein interaction among p113, ZRF1, and BRD4. j Dual-luciferase assay showing the activity of ZRF1 in NB cells stably transfected with mock, ecircCUX1 , ecircCUX1 Mut, p113 , sh-Scb, or sh-ecircCUX1 ( n = 5). Fisher’s exact test for overlapping analysis in b . ANOVA compared the difference in j . * P < 0.05 vs. mock or sh-Scb. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in c - e , g , h and j
Human Brd4 Cdna, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+cdna/brd4+sirna/pm29050985-74-1-9
Average 90 stars, based on 1 article reviews
human brd4 cdna - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Five Prime cdna encoding human brd4 (ncbi accession numbers np 055114.1)
p113 physically interacts with ZRF1 and <t>BRD4</t> in NB cells. a Volcano plots showing differentially expressed genes (fold change> 1.5, P < 0.05) in SH-SY5Y cells stably transfected with empty vector (mock) or ecircCUX1 . b Coomassie blue staining (left panel) and Venn diagram (right panel) revealing identification of p113-interacting proteins pulled down by p113 or Flag-tag antibody in SH-SY5Y cells stably transfected with 3Flag-tagged p113 , and those overlapped with transcription factors (TF) or epigenetic factors derived from ChIP-X and EpiFactors databases. c Co-IP and western blot assays indicating the interaction among p113, ZRF1, and BRD4 in SH-SY5Y and BE(2)-C cells stably transfected with mock, ecircCUX1 , scramble shRNA (sh-Scb), or sh-ecircCUX1. d Secondary co-IP assays showing protein interaction among p113, ZRF1, and BRD4 in SH-SY5Y cells stably transfected with HA-tagged p113 , Flag-tagged ZRF1 , and His-tagged BRD4 . e BiFC assay revealing the interaction of p113 with ZRF1 or BRD4 (arrowheads) in SH-SY5Y cells stably transfected with indicated constructs, with nuclei stained by DAPI. Scale bars: 10 μm. f and g Western blot assay (g) validating the knockdown of ZRF1 or BRD4 in SH-SY5Y cells stably transfected with scramble (Scb) or specific sgRNA for CRISPR interference (CRISPRi, f). Wild type (WT) cells were taken as negative controls. h Co-IP and western blot assays indicating the interaction of p113 with ZRF1 or BRD4 in SH-SY5Y cells stably transfected with mock or ecircCUX1 , and those co-transfected with CRISPRi sgRNA specific against ZRF1 or BRD4 . i Schematic illustration of protein interaction among p113, ZRF1, and BRD4. j Dual-luciferase assay showing the activity of ZRF1 in NB cells stably transfected with mock, ecircCUX1 , ecircCUX1 Mut, p113 , sh-Scb, or sh-ecircCUX1 ( n = 5). Fisher’s exact test for overlapping analysis in b . ANOVA compared the difference in j . * P < 0.05 vs. mock or sh-Scb. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in c - e , g , h and j
Cdna Encoding Human Brd4 (Ncbi Accession Numbers Np 055114.1), supplied by Five Prime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+cdna/cdna+encoding+human+brd4/10__1016_slash_j__bmc__2018__05__003-460-2-12
Average 90 stars, based on 1 article reviews
cdna encoding human brd4 (ncbi accession numbers np 055114.1) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Five Prime brd4 cdna
p113 physically interacts with ZRF1 and <t>BRD4</t> in NB cells. a Volcano plots showing differentially expressed genes (fold change> 1.5, P < 0.05) in SH-SY5Y cells stably transfected with empty vector (mock) or ecircCUX1 . b Coomassie blue staining (left panel) and Venn diagram (right panel) revealing identification of p113-interacting proteins pulled down by p113 or Flag-tag antibody in SH-SY5Y cells stably transfected with 3Flag-tagged p113 , and those overlapped with transcription factors (TF) or epigenetic factors derived from ChIP-X and EpiFactors databases. c Co-IP and western blot assays indicating the interaction among p113, ZRF1, and BRD4 in SH-SY5Y and BE(2)-C cells stably transfected with mock, ecircCUX1 , scramble shRNA (sh-Scb), or sh-ecircCUX1. d Secondary co-IP assays showing protein interaction among p113, ZRF1, and BRD4 in SH-SY5Y cells stably transfected with HA-tagged p113 , Flag-tagged ZRF1 , and His-tagged BRD4 . e BiFC assay revealing the interaction of p113 with ZRF1 or BRD4 (arrowheads) in SH-SY5Y cells stably transfected with indicated constructs, with nuclei stained by DAPI. Scale bars: 10 μm. f and g Western blot assay (g) validating the knockdown of ZRF1 or BRD4 in SH-SY5Y cells stably transfected with scramble (Scb) or specific sgRNA for CRISPR interference (CRISPRi, f). Wild type (WT) cells were taken as negative controls. h Co-IP and western blot assays indicating the interaction of p113 with ZRF1 or BRD4 in SH-SY5Y cells stably transfected with mock or ecircCUX1 , and those co-transfected with CRISPRi sgRNA specific against ZRF1 or BRD4 . i Schematic illustration of protein interaction among p113, ZRF1, and BRD4. j Dual-luciferase assay showing the activity of ZRF1 in NB cells stably transfected with mock, ecircCUX1 , ecircCUX1 Mut, p113 , sh-Scb, or sh-ecircCUX1 ( n = 5). Fisher’s exact test for overlapping analysis in b . ANOVA compared the difference in j . * P < 0.05 vs. mock or sh-Scb. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in c - e , g , h and j
Brd4 Cdna, supplied by Five Prime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+cdna/cdna+encoding+human+brd4/us09975896-2327-16-46
Average 90 stars, based on 1 article reviews
brd4 cdna - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Unigene mouse brd4 cdna
Effects of <t>BRD4</t> depletion and inhibition on mRNA and protein expression of Adipoq and lipid droplet accumulation in 3T3-L1 adipocytes. ( a ) mRNA levels of Brd4 and protein levels of BRD4, BRD2, TRAP220, CYCLIN T1, CDK9, PPARγ2, and TATA box-binding protein (TBP) at 2 and 8 days after differentiation stimulation. Control or Brd4 shRNA-expressing 3T3-L1 cells were treated with medium for differentiation. ( b ) Levels of Adipoq mRNA in cells and ADIPOQ protein in medium at 2 and 8 days after differentiation stimulation. ( c ) Lipid droplet accumulation at 5 days after differentiation stimulation (Oil red analysis). ( d ) Adipoq mRNA in 3T3-L1 adipocytes, secreted ADIPOQ protein in the medium, and protein levels of BRD4, BRD2 and TBP in cells. (+)-JQ1 treatment of 3T3-L1 adipocytes was performed for 4 days from the adipocyte differentiation. ( e ) Lipid droplet accumulation (Oil red O analysis). The data shown are means ± SEM of 6 wells per condition. ** P < 0.01 versus the corresponding control cells by Student’s t -test ( a , b ) or Dunnett’s test based on analysis of variance ( d ).
Mouse Brd4 Cdna, supplied by Unigene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+cdna/mouse+brd4+cdna/pmc05607256-174-6-9
Average 90 stars, based on 1 article reviews
mouse brd4 cdna - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


p113 physically interacts with ZRF1 and BRD4 in NB cells. a Volcano plots showing differentially expressed genes (fold change> 1.5, P < 0.05) in SH-SY5Y cells stably transfected with empty vector (mock) or ecircCUX1 . b Coomassie blue staining (left panel) and Venn diagram (right panel) revealing identification of p113-interacting proteins pulled down by p113 or Flag-tag antibody in SH-SY5Y cells stably transfected with 3Flag-tagged p113 , and those overlapped with transcription factors (TF) or epigenetic factors derived from ChIP-X and EpiFactors databases. c Co-IP and western blot assays indicating the interaction among p113, ZRF1, and BRD4 in SH-SY5Y and BE(2)-C cells stably transfected with mock, ecircCUX1 , scramble shRNA (sh-Scb), or sh-ecircCUX1. d Secondary co-IP assays showing protein interaction among p113, ZRF1, and BRD4 in SH-SY5Y cells stably transfected with HA-tagged p113 , Flag-tagged ZRF1 , and His-tagged BRD4 . e BiFC assay revealing the interaction of p113 with ZRF1 or BRD4 (arrowheads) in SH-SY5Y cells stably transfected with indicated constructs, with nuclei stained by DAPI. Scale bars: 10 μm. f and g Western blot assay (g) validating the knockdown of ZRF1 or BRD4 in SH-SY5Y cells stably transfected with scramble (Scb) or specific sgRNA for CRISPR interference (CRISPRi, f). Wild type (WT) cells were taken as negative controls. h Co-IP and western blot assays indicating the interaction of p113 with ZRF1 or BRD4 in SH-SY5Y cells stably transfected with mock or ecircCUX1 , and those co-transfected with CRISPRi sgRNA specific against ZRF1 or BRD4 . i Schematic illustration of protein interaction among p113, ZRF1, and BRD4. j Dual-luciferase assay showing the activity of ZRF1 in NB cells stably transfected with mock, ecircCUX1 , ecircCUX1 Mut, p113 , sh-Scb, or sh-ecircCUX1 ( n = 5). Fisher’s exact test for overlapping analysis in b . ANOVA compared the difference in j . * P < 0.05 vs. mock or sh-Scb. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in c - e , g , h and j

Journal: Molecular Cancer

Article Title: p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation

doi: 10.1186/s12943-021-01421-8

Figure Lengend Snippet: p113 physically interacts with ZRF1 and BRD4 in NB cells. a Volcano plots showing differentially expressed genes (fold change> 1.5, P < 0.05) in SH-SY5Y cells stably transfected with empty vector (mock) or ecircCUX1 . b Coomassie blue staining (left panel) and Venn diagram (right panel) revealing identification of p113-interacting proteins pulled down by p113 or Flag-tag antibody in SH-SY5Y cells stably transfected with 3Flag-tagged p113 , and those overlapped with transcription factors (TF) or epigenetic factors derived from ChIP-X and EpiFactors databases. c Co-IP and western blot assays indicating the interaction among p113, ZRF1, and BRD4 in SH-SY5Y and BE(2)-C cells stably transfected with mock, ecircCUX1 , scramble shRNA (sh-Scb), or sh-ecircCUX1. d Secondary co-IP assays showing protein interaction among p113, ZRF1, and BRD4 in SH-SY5Y cells stably transfected with HA-tagged p113 , Flag-tagged ZRF1 , and His-tagged BRD4 . e BiFC assay revealing the interaction of p113 with ZRF1 or BRD4 (arrowheads) in SH-SY5Y cells stably transfected with indicated constructs, with nuclei stained by DAPI. Scale bars: 10 μm. f and g Western blot assay (g) validating the knockdown of ZRF1 or BRD4 in SH-SY5Y cells stably transfected with scramble (Scb) or specific sgRNA for CRISPR interference (CRISPRi, f). Wild type (WT) cells were taken as negative controls. h Co-IP and western blot assays indicating the interaction of p113 with ZRF1 or BRD4 in SH-SY5Y cells stably transfected with mock or ecircCUX1 , and those co-transfected with CRISPRi sgRNA specific against ZRF1 or BRD4 . i Schematic illustration of protein interaction among p113, ZRF1, and BRD4. j Dual-luciferase assay showing the activity of ZRF1 in NB cells stably transfected with mock, ecircCUX1 , ecircCUX1 Mut, p113 , sh-Scb, or sh-ecircCUX1 ( n = 5). Fisher’s exact test for overlapping analysis in b . ANOVA compared the difference in j . * P < 0.05 vs. mock or sh-Scb. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in c - e , g , h and j

Article Snippet: Human p113 ORF (342 bp), ZRF1 cDNA (1866 bp), and BRD4 cDNA (4089 bp) were subcloned into pBiFC-VN173 or pBiFC-VC155 (Addgene), and co-transfected into tumor cells with Lipofectamine 2000 (Invitrogen) for 24 h. The fluorescence was observed with a confocal microscope (Nikon, Japan) [ , , ].

Techniques: Stable Transfection, Transfection, Plasmid Preparation, Staining, FLAG-tag, Derivative Assay, Co-Immunoprecipitation Assay, Western Blot, shRNA, Bimolecular Fluorescence Complementation Assay, Construct, CRISPR, Luciferase, Activity Assay

p113/ZRF1/BRD4 complex promotes lipid metabolic reprogramming and mitochondrial complex I activity in NB cells. a Heatmap, distribution, and binding motif of ChIP-Seq (left panel) assay revealing genomic enrichment of ZRF1 in SH-SY5Y cells, while Venn diagram, heatmap, and GO pathway (right panel) showing identification of p113/ZRF1/BRD4 target genes by overlapping analysis of RNA-seq results upon p113 over-expression and ChIP-seq peaks of ZRF1 or BRD4. b ChIP-seq assay showing the binding peak of BRD4 or ZRF1 on promoter regions of ALDH3A1 , NDUFA1 , or NDUFAF5 in SH-SY5Y cells. c Western blot assay indicating the expression of ALDH3A1, NDUFA1, or NDUFAF5 in SH-SY5Y cells stably transfected with empty vector (mock) or ecircCUX1 , and those co-transfected with sgRNA specific against ZRF1 or BRD4 for CRISPRi. d Schematic illustration showing the involvement of ALDH3A1, NDUFA1, or NDUFAF5 in lipid metabolic reprogramming and mitochondrial respiratory activity. e Relative OCR levels in SH-SY5Y cells stably transfected with mock or ecircCUX1 , and those co-transfected with sgRNA specific against ZRF1 or BRD4 for CRISPRi ( n = 5). f Relative fatty acid levels, complex I activity, NAD + /NADH ratio, and ATP levels in SH-SY5Y cells stably transfected with mock or ecircCUX1 , and those co-transfected with sgRNA specific against ZRF1 or BRD4 for CRISPRi ( n = 5). ANOVA compared the difference in e and f . * P < 0.05 vs. mock+CRISPRi-Scb. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in c , e and f

Journal: Molecular Cancer

Article Title: p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation

doi: 10.1186/s12943-021-01421-8

Figure Lengend Snippet: p113/ZRF1/BRD4 complex promotes lipid metabolic reprogramming and mitochondrial complex I activity in NB cells. a Heatmap, distribution, and binding motif of ChIP-Seq (left panel) assay revealing genomic enrichment of ZRF1 in SH-SY5Y cells, while Venn diagram, heatmap, and GO pathway (right panel) showing identification of p113/ZRF1/BRD4 target genes by overlapping analysis of RNA-seq results upon p113 over-expression and ChIP-seq peaks of ZRF1 or BRD4. b ChIP-seq assay showing the binding peak of BRD4 or ZRF1 on promoter regions of ALDH3A1 , NDUFA1 , or NDUFAF5 in SH-SY5Y cells. c Western blot assay indicating the expression of ALDH3A1, NDUFA1, or NDUFAF5 in SH-SY5Y cells stably transfected with empty vector (mock) or ecircCUX1 , and those co-transfected with sgRNA specific against ZRF1 or BRD4 for CRISPRi. d Schematic illustration showing the involvement of ALDH3A1, NDUFA1, or NDUFAF5 in lipid metabolic reprogramming and mitochondrial respiratory activity. e Relative OCR levels in SH-SY5Y cells stably transfected with mock or ecircCUX1 , and those co-transfected with sgRNA specific against ZRF1 or BRD4 for CRISPRi ( n = 5). f Relative fatty acid levels, complex I activity, NAD + /NADH ratio, and ATP levels in SH-SY5Y cells stably transfected with mock or ecircCUX1 , and those co-transfected with sgRNA specific against ZRF1 or BRD4 for CRISPRi ( n = 5). ANOVA compared the difference in e and f . * P < 0.05 vs. mock+CRISPRi-Scb. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in c , e and f

Article Snippet: Human p113 ORF (342 bp), ZRF1 cDNA (1866 bp), and BRD4 cDNA (4089 bp) were subcloned into pBiFC-VN173 or pBiFC-VC155 (Addgene), and co-transfected into tumor cells with Lipofectamine 2000 (Invitrogen) for 24 h. The fluorescence was observed with a confocal microscope (Nikon, Japan) [ , , ].

Techniques: Activity Assay, Binding Assay, ChIP-sequencing, RNA Sequencing Assay, Over Expression, Western Blot, Expressing, Stable Transfection, Transfection, Plasmid Preparation

Therapeutic blocking p113-ZRF1 interaction inhibits NB progression. a 3D structure and sequences of inhibitory peptides (ZIP-12) for blocking interaction between p113 and ZRF1, and those of mutant control (Ctrl) peptides. b Confocal images showing the distribution of synthesized FITC-labeled Ctrl or ZIP-12 peptides (20 μmol·L − 1 , arrowheads) within cultured BE(2)-C cells, with nuclei and cellular membranes staining with DAPI or Dil. Scale bars: 10 μm. c Co-IP and western blot assays indicating the interaction of p113 with ZRF1 or BRD4 in BE(2)-C cells treated with Ctrl or ZIP-12 peptides (20 μmol·L − 1 ) for 24 h. d Relative fatty acid levels, complex I activity, NAD + /NADH ratio, and ATP levels in BE(2)-C cells treated with Ctrl or ZIP-12 peptides (20 μmol·L − 1 ) for 24 h. e In vivo images (left upper panel), growth curve (right panel), and weight at the end points (right panel) of xenografts formed by subcutaneous injection of BE(2)-C cells in nude mice ( n = 5 per group) that were treated with intravenous injection of Ctrl or ZIP-12 peptides (5 mg·kg − 1 ) as indicated (left lower panel). f In vivo imaging (left panel), lung metastatic colonization (right lower panel), and Kaplan–Meier curves (right lower panel) of nude mice ( n = 5 for each group) treated with tail vein injection of BE(2)-C cells, Ctrl or ZIP-12 peptides (5 mg·kg − 1 ) as indicated (right upper panel). Student’s t test or ANOVA compared the difference in d - f . Log-rank test for survival comparison in f . * P < 0.05, ** P < 0.01 vs. Ctrl. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in b - d

Journal: Molecular Cancer

Article Title: p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation

doi: 10.1186/s12943-021-01421-8

Figure Lengend Snippet: Therapeutic blocking p113-ZRF1 interaction inhibits NB progression. a 3D structure and sequences of inhibitory peptides (ZIP-12) for blocking interaction between p113 and ZRF1, and those of mutant control (Ctrl) peptides. b Confocal images showing the distribution of synthesized FITC-labeled Ctrl or ZIP-12 peptides (20 μmol·L − 1 , arrowheads) within cultured BE(2)-C cells, with nuclei and cellular membranes staining with DAPI or Dil. Scale bars: 10 μm. c Co-IP and western blot assays indicating the interaction of p113 with ZRF1 or BRD4 in BE(2)-C cells treated with Ctrl or ZIP-12 peptides (20 μmol·L − 1 ) for 24 h. d Relative fatty acid levels, complex I activity, NAD + /NADH ratio, and ATP levels in BE(2)-C cells treated with Ctrl or ZIP-12 peptides (20 μmol·L − 1 ) for 24 h. e In vivo images (left upper panel), growth curve (right panel), and weight at the end points (right panel) of xenografts formed by subcutaneous injection of BE(2)-C cells in nude mice ( n = 5 per group) that were treated with intravenous injection of Ctrl or ZIP-12 peptides (5 mg·kg − 1 ) as indicated (left lower panel). f In vivo imaging (left panel), lung metastatic colonization (right lower panel), and Kaplan–Meier curves (right lower panel) of nude mice ( n = 5 for each group) treated with tail vein injection of BE(2)-C cells, Ctrl or ZIP-12 peptides (5 mg·kg − 1 ) as indicated (right upper panel). Student’s t test or ANOVA compared the difference in d - f . Log-rank test for survival comparison in f . * P < 0.05, ** P < 0.01 vs. Ctrl. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in b - d

Article Snippet: Human p113 ORF (342 bp), ZRF1 cDNA (1866 bp), and BRD4 cDNA (4089 bp) were subcloned into pBiFC-VN173 or pBiFC-VC155 (Addgene), and co-transfected into tumor cells with Lipofectamine 2000 (Invitrogen) for 24 h. The fluorescence was observed with a confocal microscope (Nikon, Japan) [ , , ].

Techniques: Blocking Assay, Mutagenesis, Synthesized, Labeling, Cell Culture, Staining, Co-Immunoprecipitation Assay, Western Blot, Activity Assay, In Vivo, Injection, In Vivo Imaging

CUX1 , ZRF1 , BRD4 and target genes are associated with poor outcome of NB patients. a Kaplan–Meier curves indicating overall survival of 498 well-defined NB cases (GSE62564) with high or low expression of CUX1 (cutoff value = 32.233), ZRF1 (cutoff value = 21.749), BRD4 (cutoff value = 652.58), ALDH3A1 (cutoff value = 1.181), NDUFA1 (cutoff value = 22.511), or NDUFAF5 (cutoff value = 7.964). b The positive expression correlation between ZRF1 and ALDH3A1 , NDUFA1 , or NDUFAF5 in 498 well-defined NB cases (GSE62564). c The mechanisms underlying p113-faciliated NB progression: as a novel protein encoded by ecircCUX1 , p113 cooperates with ZRF1 and BRD4 to activate the transcription of ALDH3A1 , NDUFA1 , or NDUFAF5 , resulting in promoted conversion of fatty aldehydes into fatty acids, fatty acid β-oxidation, mitochondrial complex I activity, growth, and aggressiveness of NB cells. Meanwhile, inhibitory peptides (ZIP-12) blocking p113-ZRF1 interaction suppresses tumor progression. Log-rank test for survival comparison in a . Pearson’s correlation coefficient for b

Journal: Molecular Cancer

Article Title: p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation

doi: 10.1186/s12943-021-01421-8

Figure Lengend Snippet: CUX1 , ZRF1 , BRD4 and target genes are associated with poor outcome of NB patients. a Kaplan–Meier curves indicating overall survival of 498 well-defined NB cases (GSE62564) with high or low expression of CUX1 (cutoff value = 32.233), ZRF1 (cutoff value = 21.749), BRD4 (cutoff value = 652.58), ALDH3A1 (cutoff value = 1.181), NDUFA1 (cutoff value = 22.511), or NDUFAF5 (cutoff value = 7.964). b The positive expression correlation between ZRF1 and ALDH3A1 , NDUFA1 , or NDUFAF5 in 498 well-defined NB cases (GSE62564). c The mechanisms underlying p113-faciliated NB progression: as a novel protein encoded by ecircCUX1 , p113 cooperates with ZRF1 and BRD4 to activate the transcription of ALDH3A1 , NDUFA1 , or NDUFAF5 , resulting in promoted conversion of fatty aldehydes into fatty acids, fatty acid β-oxidation, mitochondrial complex I activity, growth, and aggressiveness of NB cells. Meanwhile, inhibitory peptides (ZIP-12) blocking p113-ZRF1 interaction suppresses tumor progression. Log-rank test for survival comparison in a . Pearson’s correlation coefficient for b

Article Snippet: Human p113 ORF (342 bp), ZRF1 cDNA (1866 bp), and BRD4 cDNA (4089 bp) were subcloned into pBiFC-VN173 or pBiFC-VC155 (Addgene), and co-transfected into tumor cells with Lipofectamine 2000 (Invitrogen) for 24 h. The fluorescence was observed with a confocal microscope (Nikon, Japan) [ , , ].

Techniques: Expressing, Activity Assay, Blocking Assay

Effects of BRD4 depletion and inhibition on mRNA and protein expression of Adipoq and lipid droplet accumulation in 3T3-L1 adipocytes. ( a ) mRNA levels of Brd4 and protein levels of BRD4, BRD2, TRAP220, CYCLIN T1, CDK9, PPARγ2, and TATA box-binding protein (TBP) at 2 and 8 days after differentiation stimulation. Control or Brd4 shRNA-expressing 3T3-L1 cells were treated with medium for differentiation. ( b ) Levels of Adipoq mRNA in cells and ADIPOQ protein in medium at 2 and 8 days after differentiation stimulation. ( c ) Lipid droplet accumulation at 5 days after differentiation stimulation (Oil red analysis). ( d ) Adipoq mRNA in 3T3-L1 adipocytes, secreted ADIPOQ protein in the medium, and protein levels of BRD4, BRD2 and TBP in cells. (+)-JQ1 treatment of 3T3-L1 adipocytes was performed for 4 days from the adipocyte differentiation. ( e ) Lipid droplet accumulation (Oil red O analysis). The data shown are means ± SEM of 6 wells per condition. ** P < 0.01 versus the corresponding control cells by Student’s t -test ( a , b ) or Dunnett’s test based on analysis of variance ( d ).

Journal: Scientific Reports

Article Title: BRD4 regulates adiponectin gene induction by recruiting the P-TEFb complex to the transcribed region of the gene

doi: 10.1038/s41598-017-12342-2

Figure Lengend Snippet: Effects of BRD4 depletion and inhibition on mRNA and protein expression of Adipoq and lipid droplet accumulation in 3T3-L1 adipocytes. ( a ) mRNA levels of Brd4 and protein levels of BRD4, BRD2, TRAP220, CYCLIN T1, CDK9, PPARγ2, and TATA box-binding protein (TBP) at 2 and 8 days after differentiation stimulation. Control or Brd4 shRNA-expressing 3T3-L1 cells were treated with medium for differentiation. ( b ) Levels of Adipoq mRNA in cells and ADIPOQ protein in medium at 2 and 8 days after differentiation stimulation. ( c ) Lipid droplet accumulation at 5 days after differentiation stimulation (Oil red analysis). ( d ) Adipoq mRNA in 3T3-L1 adipocytes, secreted ADIPOQ protein in the medium, and protein levels of BRD4, BRD2 and TBP in cells. (+)-JQ1 treatment of 3T3-L1 adipocytes was performed for 4 days from the adipocyte differentiation. ( e ) Lipid droplet accumulation (Oil red O analysis). The data shown are means ± SEM of 6 wells per condition. ** P < 0.01 versus the corresponding control cells by Student’s t -test ( a , b ) or Dunnett’s test based on analysis of variance ( d ).

Article Snippet: For preparation of BRD4-overexpressing cells, a mouse Brd4 cDNA (Unigene ID Mm.

Techniques: Inhibition, Expressing, Binding Assay, Control, shRNA

Effects of BRD4 depletion on binding of BRD4, acetylated histones, P-TEFb, PPARγ2, and TRAP220 around the Adipoq gene in 3T3-L1 adipocytes. Control or Brd4 shRNA-expressing 3T3-L1 cells were treated with medium for differentiation. ChIP assays for BRD4, acetylated histone H3, acetylated histone H4, CDK9, PPARγ2, TRAP220, and normal IgG were performed at 2 and 8 days after differentiation. The data shown are means ± SEM of 6 wells per condition in a single experiment. * P < 0.05, ** P < 0.01 versus the corresponding control cells by Student’s t -test.

Journal: Scientific Reports

Article Title: BRD4 regulates adiponectin gene induction by recruiting the P-TEFb complex to the transcribed region of the gene

doi: 10.1038/s41598-017-12342-2

Figure Lengend Snippet: Effects of BRD4 depletion on binding of BRD4, acetylated histones, P-TEFb, PPARγ2, and TRAP220 around the Adipoq gene in 3T3-L1 adipocytes. Control or Brd4 shRNA-expressing 3T3-L1 cells were treated with medium for differentiation. ChIP assays for BRD4, acetylated histone H3, acetylated histone H4, CDK9, PPARγ2, TRAP220, and normal IgG were performed at 2 and 8 days after differentiation. The data shown are means ± SEM of 6 wells per condition in a single experiment. * P < 0.05, ** P < 0.01 versus the corresponding control cells by Student’s t -test.

Article Snippet: For preparation of BRD4-overexpressing cells, a mouse Brd4 cDNA (Unigene ID Mm.

Techniques: Binding Assay, Control, shRNA, Expressing

Effects of BRD4 depletion on expression of genes related to insulin sensitivity in 3T3-L1 adipocytes. Control or Brd4 shRNA-expressing 3T3-L1 cells were treated with medium for differentiation and real-time RT-PCR analyses for Albp , Glut4 , Fas , Accα , Accβ , Dgat1 , Lpl , Hsl , Aco , Pparγ1 , Pparγ2 , Creb , C/ebpα , C/ebpβ , C/ebpδ , C/ebpγ , C/ebpζ , Chrebp , Pgc1α , Srebp1 , Srebp1α , Lxrα and Lxrβ were performed at 2 and 8 days after differentiation stimulation. The data shown are means ± SEM of 6 wells per condition in a single experiment. * P < 0.05, ** P < 0.01 versus the corresponding control cells by Student’s t -test.

Journal: Scientific Reports

Article Title: BRD4 regulates adiponectin gene induction by recruiting the P-TEFb complex to the transcribed region of the gene

doi: 10.1038/s41598-017-12342-2

Figure Lengend Snippet: Effects of BRD4 depletion on expression of genes related to insulin sensitivity in 3T3-L1 adipocytes. Control or Brd4 shRNA-expressing 3T3-L1 cells were treated with medium for differentiation and real-time RT-PCR analyses for Albp , Glut4 , Fas , Accα , Accβ , Dgat1 , Lpl , Hsl , Aco , Pparγ1 , Pparγ2 , Creb , C/ebpα , C/ebpβ , C/ebpδ , C/ebpγ , C/ebpζ , Chrebp , Pgc1α , Srebp1 , Srebp1α , Lxrα and Lxrβ were performed at 2 and 8 days after differentiation stimulation. The data shown are means ± SEM of 6 wells per condition in a single experiment. * P < 0.05, ** P < 0.01 versus the corresponding control cells by Student’s t -test.

Article Snippet: For preparation of BRD4-overexpressing cells, a mouse Brd4 cDNA (Unigene ID Mm.

Techniques: Expressing, Control, shRNA, Quantitative RT-PCR

Effects of BRD4 overexpression on Brd4 mRNA and protein levels and mRNA levels of genes related to insulin sensitivity in 3T3-L1 adipocytes. Brd4 -overexpressing or control plasmid transfected 3T3-L1 cells were treated with medium for differentiation. Immunoblot analysis for BRD4, CYCLIN T1, CDK9, PPARγ2 and TBP and real-time RT-PCR analyses for Brd4 , Adipoq , Albp , Glut4 , Fas , Accα , Accβ , Dgat1 , Lpl , Hsl , Aco , Pparγ1 , Pparγ2 , Creb , C/ebpα , C/ebpβ , C/ebpδ , C/ebpγ , C/ebpζ , Chrebp , Pgc1α , Srebp1 , Srebp1α , Lxrα and Lxrβ were performed in samples at 2 days after differentiation. The data shown are means ± SEM of 6 wells per condition in a single experiment. * P < 0.05, ** P < 0.01 versus the corresponding control cells by Student’s t -test.

Journal: Scientific Reports

Article Title: BRD4 regulates adiponectin gene induction by recruiting the P-TEFb complex to the transcribed region of the gene

doi: 10.1038/s41598-017-12342-2

Figure Lengend Snippet: Effects of BRD4 overexpression on Brd4 mRNA and protein levels and mRNA levels of genes related to insulin sensitivity in 3T3-L1 adipocytes. Brd4 -overexpressing or control plasmid transfected 3T3-L1 cells were treated with medium for differentiation. Immunoblot analysis for BRD4, CYCLIN T1, CDK9, PPARγ2 and TBP and real-time RT-PCR analyses for Brd4 , Adipoq , Albp , Glut4 , Fas , Accα , Accβ , Dgat1 , Lpl , Hsl , Aco , Pparγ1 , Pparγ2 , Creb , C/ebpα , C/ebpβ , C/ebpδ , C/ebpγ , C/ebpζ , Chrebp , Pgc1α , Srebp1 , Srebp1α , Lxrα and Lxrβ were performed in samples at 2 days after differentiation. The data shown are means ± SEM of 6 wells per condition in a single experiment. * P < 0.05, ** P < 0.01 versus the corresponding control cells by Student’s t -test.

Article Snippet: For preparation of BRD4-overexpressing cells, a mouse Brd4 cDNA (Unigene ID Mm.

Techniques: Over Expression, Control, Plasmid Preparation, Transfection, Western Blot, Quantitative RT-PCR

Effects of Brd4 genetic depletion on Adipoq and fatty acid synthesis-related gene expression in mesenteric fat tissues and ADIPOQ protein in serum during postnatal development of mice. ( a ) Genotypes. ( b ) mRNA levels of Adipoq and genes related to fatty acid synthesis ( Albp , Fas , Accα and Accβ ) and fatty acid oxidation ( Aco ). ( c ) Serum ADIPOQ concentration. The data shown are means ± SEM for 5–11 mice per group in a single experiment. * P < 0.05, ** P < 0.01 versus the corresponding control cells by Student’s t -test.

Journal: Scientific Reports

Article Title: BRD4 regulates adiponectin gene induction by recruiting the P-TEFb complex to the transcribed region of the gene

doi: 10.1038/s41598-017-12342-2

Figure Lengend Snippet: Effects of Brd4 genetic depletion on Adipoq and fatty acid synthesis-related gene expression in mesenteric fat tissues and ADIPOQ protein in serum during postnatal development of mice. ( a ) Genotypes. ( b ) mRNA levels of Adipoq and genes related to fatty acid synthesis ( Albp , Fas , Accα and Accβ ) and fatty acid oxidation ( Aco ). ( c ) Serum ADIPOQ concentration. The data shown are means ± SEM for 5–11 mice per group in a single experiment. * P < 0.05, ** P < 0.01 versus the corresponding control cells by Student’s t -test.

Article Snippet: For preparation of BRD4-overexpressing cells, a mouse Brd4 cDNA (Unigene ID Mm.

Techniques: Gene Expression, Concentration Assay, Control